---
figid: PMC7312018__ijms-21-04158-g004
figlink: pmc/articles/PMC7312018/figure/ijms-21-04158-f004/
number: F4
caption: Tamoxifen modulation of membrane and nuclear estrogen receptor (ER) signaling.
  Transduction of the extracellular environment occurs at the cell membrane. This
  is mediated by transforming growth factor-β1 receptor (TGFβ-R), integrin linked
  kinase (ILK), caveolin ion channels and membrane bound receptor tyrosine kinases
  (RTKs), for example, epidermal growth factor receptor (EGFR). In the TGF-β1 canonical
  pathway, TGF-β1 first binds to TβR-II, and then the recruitment of TβR-I occurs.
  Both receptors then form the TβR complex, in which TβR-II phosphorylates and activates
  TβR-I. The active TβR-I then phosphorylates SMAD2/3. This results in the cytoplasmic
  retention of p-SMAD2/3 and association with SMAD4. The resulting SMAD complex is
  translocated to the nucleus and activates SMAD-dependent transcriptional activity.
  SMAD7 decreases the stability and activity of TβR-I by inducing receptor degradation.
  SMAD7 also competes with SMAD4 to associate with SMAD 2/3. Tamoxifen blocks canonical
  TGF-β1 signaling by inhibiting SMAD2/3 and promoting SMAD7 (red blockade arrows).
  The activation of the non-receptor tyrosine kinase Src occurs via the phosphorylation
  of membrane bound RTKs, including estrogen receptor alpha (ER-α). There is a reciprocal
  phosphorylation of Src, ER-α and RTKs—this is dependent, in part, on the tissue
  levels of tamoxifen and the expression levels of membrane ER-α. Estrogen, tamoxifen
  and fulvestrant are agonists of G protein-coupled estrogen receptor-1 (GPER-1).
  Estrogen regulates Hippo signaling via GPER in breast cancer by phospholipase C
  (PLC), protein kinase C (PKC), Yes associated protein (YAP), and transcriptional
  coactivator with PDZ-binding motif (TAZ). In ER-α negative breast cancers, GPER
  activation turns on the Hippo pathway, causing the phosphorylation of YAP and the
  cytoplasmic retention of pYAP, which is then marked for proteosomal degradation.
  However, when the Hippo pathway is turned off (for example by aberrant Src activation),
  unphosphorylated YAP is able to be translocated to the nucleus and activate transcription
  targets. Estrogen receptors also influence non-canonical TGF-β1 signaling via PI3K
  (phosphatidylinositol 3-kinase) and Akt (Protein Kinase B) pathways. Tamoxifen can
  act as an ER-α antagonist in some tissues (breast) and an ER-α agonist in others
  (endometrium, osteoblasts, endothelium), hence its pleiotropic effects. It is thus
  classified as a selective estrogen receptor modulator (SERM) [,].
pmcid: PMC7312018
papertitle: Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal
  Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition.
reftext: Robert B. Wilson, et al. Int J Mol Sci. 2020 Jun;21(11):4158.
pmc_ranked_result_index: '84938'
pathway_score: 0.9618375
filename: ijms-21-04158-g004.jpg
figtitle: Tamoxifen modulation of membrane and nuclear estrogen receptor (ER) signaling
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7312018__ijms-21-04158-g004.html
  '@type': Dataset
  description: Tamoxifen modulation of membrane and nuclear estrogen receptor (ER)
    signaling. Transduction of the extracellular environment occurs at the cell membrane.
    This is mediated by transforming growth factor-β1 receptor (TGFβ-R), integrin
    linked kinase (ILK), caveolin ion channels and membrane bound receptor tyrosine
    kinases (RTKs), for example, epidermal growth factor receptor (EGFR). In the TGF-β1
    canonical pathway, TGF-β1 first binds to TβR-II, and then the recruitment of TβR-I
    occurs. Both receptors then form the TβR complex, in which TβR-II phosphorylates
    and activates TβR-I. The active TβR-I then phosphorylates SMAD2/3. This results
    in the cytoplasmic retention of p-SMAD2/3 and association with SMAD4. The resulting
    SMAD complex is translocated to the nucleus and activates SMAD-dependent transcriptional
    activity. SMAD7 decreases the stability and activity of TβR-I by inducing receptor
    degradation. SMAD7 also competes with SMAD4 to associate with SMAD 2/3. Tamoxifen
    blocks canonical TGF-β1 signaling by inhibiting SMAD2/3 and promoting SMAD7 (red
    blockade arrows). The activation of the non-receptor tyrosine kinase Src occurs
    via the phosphorylation of membrane bound RTKs, including estrogen receptor alpha
    (ER-α). There is a reciprocal phosphorylation of Src, ER-α and RTKs—this is dependent,
    in part, on the tissue levels of tamoxifen and the expression levels of membrane
    ER-α. Estrogen, tamoxifen and fulvestrant are agonists of G protein-coupled estrogen
    receptor-1 (GPER-1). Estrogen regulates Hippo signaling via GPER in breast cancer
    by phospholipase C (PLC), protein kinase C (PKC), Yes associated protein (YAP),
    and transcriptional coactivator with PDZ-binding motif (TAZ). In ER-α negative
    breast cancers, GPER activation turns on the Hippo pathway, causing the phosphorylation
    of YAP and the cytoplasmic retention of pYAP, which is then marked for proteosomal
    degradation. However, when the Hippo pathway is turned off (for example by aberrant
    Src activation), unphosphorylated YAP is able to be translocated to the nucleus
    and activate transcription targets. Estrogen receptors also influence non-canonical
    TGF-β1 signaling via PI3K (phosphatidylinositol 3-kinase) and Akt (Protein Kinase
    B) pathways. Tamoxifen can act as an ER-α antagonist in some tissues (breast)
    and an ER-α agonist in others (endometrium, osteoblasts, endothelium), hence its
    pleiotropic effects. It is thus classified as a selective estrogen receptor modulator
    (SERM) [,].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - EGF
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - EGFR
  - GPER1
  - HRAS
  - KRAS
  - NRAS
  - ILK
  - PLCB3
  - PLCB4
  - PLCG1
  - PLCB1
  - PLCE1
  - PLCD4
  - PLCD3
  - PLCB2
  - PLCD1
  - PLCG2
  - PLCZ1
  - SMAD1
  - SMAD2
  - SMAD5
  - SMAD6
  - SMAD9
  - SMAD3
  - SMAD4
  - SMAD7
  - ARAF
  - BRAF
  - RAF1
  - PRKACG
  - PRKAR1A
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKAR1B
  - ATF2
  - CREB5
  - CREB3
  - CREB3L3
  - ATF1
  - CREB1
  - CREM
  - CREB3L2
  - CREB3L1
  - CREB3L4
  - SRC
  - MAPK3
  - MAPK1
  - AKT2
  - AKT3
  - AKT1
  - YY1AP1
  - TF
  - Estrogen
  - TAM
  - Ca2+
genes:
- word: TGFB-1
  symbol: TGFB1
  source: hgnc_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: TGFB-R
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: TGFB-R
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: TGFB-R
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR3
  entrez: '7049'
- word: EGF-R
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: GPER-1
  symbol: GPER1
  source: hgnc_symbol
  hgnc_symbol: GPER1
  entrez: '2852'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ILK
  symbol: ILK
  source: hgnc_symbol
  hgnc_symbol: ILK
  entrez: '3611'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: YAP/TAZO
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: TF
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
- word: TF
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
chemicals:
- word: Estrogen
  source: MESH
  identifier: D004967
- word: TAM
  source: MESH
  identifier: C419191
- word: Ca2+
  source: MESH
  identifier: D002118
diseases: []
figid_alias: PMC7312018__F4
redirect_from: /figures/PMC7312018__F4
figtype: Figure
---
